(Press-News.org) The Buck Institute for Research on Aging has secured a significant contract from the Defense Advanced Research Projects Agency (DARPA) to spearhead the Simulation and Inference of Microbial Behavior and Adaptation (SIMBA) project. In collaboration with DARPA's Simulating Microbial Systems (SMS) Program, this initiative will develop a cloud-based platform integrating multi-dimensional, multi-omic data to simulate the dynamic behavior of microbial cells.
Dr. James Yurkovich, Research Assistant Professor at the Buck Institute and Principal Investigator of the SIMBA Team, stated, "We are incredibly excited to lead this outstanding team in developing the next generation of whole-cell modeling technologies. Our goal is to revolutionize the way we model and predict microbial states, offering immense potential for advancing our fundamental understanding of bacterial behavior and addressing critical challenges in biomanufacturing and national security."
Current "whole-cell models"—computer programs that predict microbial behavior and function, from gene expression to protein levels within a cell—face considerable hurdles in capturing the complexity of biological systems with their vast numbers of genes and intricate interactions. The Buck Institute is leading a multi-partner team including Philancea Network Inc., Ardra Inc., and b.next among others to overcome these limitations. Together, they will develop a broadly applicable and comprehensive cloud-based computational simulation platform capable of integrating extensive multi-dimensional, multi-omic data. This powerful integration will enable the highly accurate simulation of dynamic bacterial phenotypes and behaviors, while also capturing the natural variation and stochasticity observed across individual cells within a population.
"Our advanced generative AI that leverages mechanistic knowledge will provide unprecedented insight and predictive power at the level of individual cells," said Dr. Laurence Yang, Principal and Founder at Philancea Network, Inc., who will co-lead the AI efforts. “This AI platform will enhance manufacturing efficiency by designing cell factories predictively."
The SIMBA platform will be applied to accelerate biomanufacturing processes by optimizing the design of E. coli strains for the efficient production of high-value molecules. Simultaneously, the team will work to enhance the prediction of antimicrobial efficacy, allowing for more accurate forecasting of novel antimicrobials against bacterial threats.
“This award underscores the Buck Institute’s leadership in innovative research and its commitment to tackling complex scientific challenges with significant real-world impact,” says Eric Verdin, MD, President and CEO of the Buck Institute. “The SIMBA project is poised to usher in a new era of understanding and harnessing the power of microbial systems.”
About the Buck Institute:
Our success will ultimately change healthcare. At the Buck, we aim to end the threat of age-related diseases for this and future generations by bringing together the most capable and passionate scientists from a broad range of disciplines to identify and impede the ways in which we age. An independent, nonprofit institution, our goal is to increase human healthspan, or the healthy years of life. Globally recognized as the pioneer and leader in efforts to target aging, the number one risk factor for serious diseases including Alzheimer’s, Parkinson’s, cancer, macular degeneration, heart disease, and diabetes, the Buck wants to help people live better longer. Learn more at: https://buckinstitute.org
Approved for Public Release, Distribution Unlimited
END
Buck Institute awarded DARPA contract to pioneer next-gen AI modeling platform
Research seeks to better understand how cells behave
2025-07-09
ELSE PRESS RELEASES FROM THIS DATE:
Orange is the new aphrodisiac—for guppies
2025-07-09
It turns out colour isn’t just fashionable for guppies: According to a new UBC study, the more orange a male, the more virile it is.
The research published in Nature Ecology & Evolution shines light on an enduring evolutionary mystery: why male guppies have such vibrant and varied colours and patterns.
Virile me up
Zoologists Drs. Wouter van der Bijl and Judith Mank used deep learning, genetic studies and bred three generations of increasingly orange guppies to investigate. They found the more colourful males were up to two times more sexually active, performing for females at a greater rate and for longer periods of time, and attempting to sneakily copulate ...
Murals boost Cincinnati’s vitality, community development
2025-07-09
Cities across the U.S. are increasingly turning to murals as tools for placemaking, cultural expression and neighborhood revitalization — and Cincinnati is a standout among them. With more than 300 murals across the city, including 55 in one historic district alone, public art has become a defining feature of Cincinnati’s streetscape.
Now, a new study published in the international urban design journal Cities offers fresh insights into how murals contribute to vibrant, walkable neighborhoods. The study is led by Hyesun Jeong, assistant professor of urban design in the University of Cincinnati’s School of Art at the College of Design, Architecture, Art, ...
Ad blockers may be showing users more problematic ads, NYU Tandon study finds
2025-07-09
Ad blockers, the digital shields that nearly one billion internet users deploy to protect themselves from intrusive advertising, may be inadvertently exposing their users to more problematic content, according to a new study from NYU Tandon School of Engineering.
The study, which analyzed over 1,200 advertisements across the United States and Germany, found that users of Adblock Plus's "Acceptable Ads" feature encountered 13.6% more problematic advertisements compared to users browsing ...
Verbal response time reveals hidden sleepiness in older adults
2025-07-09
A new study led by UCLA investigators shows that Verbal Reaction Time (VRT), the amount of time it takes a person to respond verbally, can be a marker of sleepiness in older adults. The study, which measured participants’ voice data through standardized cognitive assessments, show how VRT can passively detect excessive sleepiness, especially among older individuals using sedative medications.
Why it matters
Sleepiness is a major contributor to safety risks in daily life, but is often underreported or unnoticed, especially among older ...
University of Maryland School of Medicine launches groundbreaking study on THC/CBD therapy for dementia-related agitation at end of life
2025-07-09
The University of Maryland School of Medicine (UMSOM) Palliative Medicine Program has launched a new clinical trial funded by the National Institute on Aging to explore a potential treatment for agitation in patients with dementia nearing the end of life. The study focuses on an investigational oral drug, T2:C100, which contains the two active ingredients in cannabis: THC and CBD.
Currently, standard medications such as morphine, valium, and Haldol are commonly used to manage agitation in hospice-eligible patients with dementia. However, these treatments are often ineffective ...
Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery
2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.006
This new article publication from Acta Pharmaceutica Sinica B, discusses targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery.
Triple-negative breast cancer (TNBC) is aggressive, with high recurrence rates and poor prognosis. Paclitaxel (PTX) remains a key chemotherapeutic agent for TNBC, but its efficacy diminishes due to the emergence of drug resistance, largely driven by cancer stem-like cells (CSCs), vasculogenic mimicry (VM) formation and tumor immunosuppressive ...
SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts
2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.017
This new article publication from Acta Pharmaceutica Sinica B, discusses how SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts.
Idiopathic pulmonary fibrosis (IPF), a chronic interstitial lung disease, is characterized by aberrant wound healing, excessive scarring and the formation of myofibroblastic foci. Although the role of alternative splicing (AS) in the pathogenesis of organ fibrosis has garnered increasing attention, ...
Psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis
2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.001
This new article publication from Acta Pharmaceutica Sinica B, discusses how a psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis.
Ovarian tumor (OT) is the most lethal form of gynecologic malignancy, with minimal improvements in patient outcomes over the past several decades. Metastasis is the leading cause of ovarian cancer-related deaths, yet the underlying mechanisms remain poorly understood.
Psychological stress is known to activate ...
An anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 i
2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.008
This new article publication from Acta Pharmaceutica Sinica B, discusses how an anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 inflammasome activation.
The coinfection of respiratory viruses and bacteria is a major cause of morbidity and mortality worldwide, despite the development of vaccines and powerful antibiotics. As a macromolecule that is difficult to absorb in the gastrointestinal tract, a homogeneous polysaccharide from Houttuynia cordata (HCPM) has been reported ...
ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells
2025-07-09
https://doi.org/10.1016/j.apsb.2025.04.018
This new article publication from Acta Pharmaceutica Sinica B, discusses how ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells.
Chemotherapy is currently the mainstay of systemic management for triple-negative breast cancer (TNBC), but chemoresistance significantly impacts patient outcomes.
This research indicates that Doxorubicin (Dox)-resistant TNBC cells exhibit increased glycolysis and ATP generation compared to their parental cells, with this metabolic shift contributing to chemoresistance. It was discovered ...
LAST 30 PRESS RELEASES:
New electroenzymatic strategy enables non-natural oxidation reactions
Tunable laser light
Scientists uncover magnetic-field control of ultrafast spin dynamics in 2D ferromagnets
New AI-powered model accurately predicts lung motion with minimal radiation
AI language models show promise in predicting liver cancer treatment outcomes
Tracking insect and bug health in a heartbeat from a digital camera
'Talking fish' not heard by conservation policies, SFU study warns
Thirty years of research shows increased resistance in fungi
Junk food ‘avoids advertising regulation’ with top level UK sports sponsorship
Banking on AI while committed to net zero is ‘magical thinking’, claims report on energy costs of big tech
Ancient river systems reveal Mars was wetter than we thought
Online toolkit to help parents of autistic children improve dental health
The psychological and neurological parallels between sports fandom and religious devotion
Agricultural liming in the US is a large CO2 sink, say researchers
Seaside more likely to make us nostalgic than green places, study finds
Psilocybin delays aging, extends lifespan, Emory study suggests
Buck Institute awarded DARPA contract to pioneer next-gen AI modeling platform
Orange is the new aphrodisiac—for guppies
Murals boost Cincinnati’s vitality, community development
Ad blockers may be showing users more problematic ads, NYU Tandon study finds
Verbal response time reveals hidden sleepiness in older adults
University of Maryland School of Medicine launches groundbreaking study on THC/CBD therapy for dementia-related agitation at end of life
Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery
SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts
Psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis
An anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 i
ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells
A photodynamic nanohybrid system reverses hypoxia and augment anti-primary and metastatic tumor efficacy of immunotherapy
Acta Pharmaceutica Sinica B Volume 15, Issue 6 Publishes
From injury to agony: Scientists discover brain pathway that turns pain into suffering
[Press-News.org] Buck Institute awarded DARPA contract to pioneer next-gen AI modeling platformResearch seeks to better understand how cells behave